| 石志永,姚鹤峰,王文娴,等.EGFR-KDD突变并受益于靶向治疗而对免疫治疗不敏感的肺腺癌1例分析[J].肿瘤学杂志,2022,28(6):521-525. |
| EGFR-KDD突变并受益于靶向治疗而对免疫治疗不敏感的肺腺癌1例分析 |
| A Case of Lung Adenocarcinoma Patient with EGFR-KDD Mutation Benefit from Targeted Therapy and Not Sensitive to Immunotherapy |
| 投稿时间：2022-04-14 |
| DOI：10.11735/j.issn.1671-170X.2022.06.B014 |
|
 |